Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (911-920 of 1,119) with videos related to

Pageof 112
Sort By:
Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.
International Journal of Cardiology|February 15, 2020
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countriesDavid Brieger, Stuart J Pocock, Stefan Blankenberg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 24, 2024
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observationShaun G Goodman, Philippe Gabriel Steg, Michael Szarek, et al.
Circulation|May 18, 2026
Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT TrialJ Dawn Abbott, Jocelyne R Benatar, Colleen M Ballantyne, et al.
Journal of Virology|May 28, 2010
Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infectionCristian Cilloniz, Mary J Pantin-Jackwood, Chester Ni, et al.
Heart (British Cardiac Society)|April 7, 2017
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromesJoakim Alfredsson, Benjamin Neely, Megan L Neely, et al.
European Journal of Preventive Cardiology|February 8, 2025
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndromeGregory G Schwartz, Michael Szarek, Esther Reijnders, et al.
Clinical Cardiology|March 26, 2018
Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT)Olivia R Ghosh-Swaby, Mary Tan, Akshay Bagai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overviewGlenn M Chertow, Lara B Pupim, Geoffrey A Block, et al.
American Heart Journal|November 1, 2020
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registryNaveen L Pereira, Robert Avram, Derek Y So, et al.
Pageof 112

Showing results (911-920 of 1,119) with videos related to

Sort By:
Pageof 112
Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.
International Journal of Cardiology|February 15, 2020
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countriesDavid Brieger, Stuart J Pocock, Stefan Blankenberg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 24, 2024
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observationShaun G Goodman, Philippe Gabriel Steg, Michael Szarek, et al.
Circulation|May 18, 2026
Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT TrialJ Dawn Abbott, Jocelyne R Benatar, Colleen M Ballantyne, et al.
Journal of Virology|May 28, 2010
Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infectionCristian Cilloniz, Mary J Pantin-Jackwood, Chester Ni, et al.
Heart (British Cardiac Society)|April 7, 2017
Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromesJoakim Alfredsson, Benjamin Neely, Megan L Neely, et al.
European Journal of Preventive Cardiology|February 8, 2025
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndromeGregory G Schwartz, Michael Szarek, Esther Reijnders, et al.
Clinical Cardiology|March 26, 2018
Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT)Olivia R Ghosh-Swaby, Mary Tan, Akshay Bagai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overviewGlenn M Chertow, Lara B Pupim, Geoffrey A Block, et al.
American Heart Journal|November 1, 2020
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registryNaveen L Pereira, Robert Avram, Derek Y So, et al.
Pageof 112